Veriti Management LLC Gilead Sciences, Inc. Transaction History

Veriti Management LLC

$0
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$66.59 - $83.99 $267,625 - $337,555	4,019 Added 13.83%	33,089 $2.77 Million
Q2 2024 Aug 02, 2024	BUY	$63.15 - $72.88 $110,323 - $127,321	1,747 Added 6.39%	29,070 $1.99 Million
Q1 2024 Apr 19, 2024	SELL	$71.58 - $87.29 $202,857 - $247,379	-2,834 Reduced 9.4%	27,323 $2 Million
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $413,828 - $469,292	5,648 Added 23.04%	30,157 $2.44 Million
Q3 2023 Oct 27, 2023	SELL	$73.94 - $80.67 $124,145 - $135,444	-1,679 Reduced 6.41%	24,509 $1.84 Million
Q2 2023 Jul 13, 2023	SELL	$76.01 - $86.7 $60,808 - $69,360	-800 Reduced 2.96%	26,188 $2.02 Million
Q1 2023 Apr 26, 2023	BUY	$77.31 - $88.08 $81,330 - $92,660	1,052 Added 4.06%	26,988 $2.24 Million
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $314,155 - $451,018	5,041 Added 24.13%	25,936 $0
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $95,978 - $109,632	1,612 Added 8.36%	20,895 $1.29 Million
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $241,673 - $272,196	4,187 Added 27.74%	19,283 $1.19 Million
Q1 2022 Apr 11, 2022	BUY	$57.92 - $72.58 $45,351 - $56,830	783 Added 5.47%	15,096 $897,000
Q4 2021 Jan 19, 2022	SELL	$64.88 - $73.64 $2,789 - $3,166	-43 Reduced 0.3%	14,313 $1.04 Million
Q3 2021 Oct 08, 2021	BUY	$67.69 - $73.03 $140,185 - $151,245	2,071 Added 16.86%	14,356 $1 Million
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $94,824 - $103,608	1,494 Added 13.84%	12,285 $846,000
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $60,720 - $69,281	1,012 Added 10.35%	10,791 $697,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $553,980 - $631,234	9,779 New	9,779 $570,000

Others Institutions Holding GILD

# of Institutions

1,963

Shares Held

995M

Call Options Held

10.5M

Put Options Held

9.86M

Black Rock Inc. New York, NY

121M
Shares

$11.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$11.2 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.44 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$6.01 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.85 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $122B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.

Account